Coagulation disorder in children and adolescents with moderate to severe traumatic brain injury

Carolina A Affonseca1, Luís Fernando A Carvalho, Sérgio D Guerra

  • 1Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil. luiscarol@uol.com.br

Jornal De Pediatria
|June 7, 2007
PubMed

Insights

Coagulopathy is common in children with severe traumatic brain injury, linked to injury severity but not directly to mortality. It serves as an important marker of injury severity in pediatric TBI patients.

Area of Science:

  • Pediatric critical care medicine
  • Neurotrauma research
  • Hematology

Background:

  • Moderate to severe traumatic brain injury (TBI) is a significant cause of morbidity and mortality in children and adolescents.
  • Coagulation disorders are a known complication of TBI, but their specific impact in pediatric populations requires further elucidation.
  • Understanding the epidemiological profile and associated factors of coagulopathy in pediatric TBI is crucial for improving patient outcomes.

Purpose of the Study:

  • To characterize the epidemiological profile of pediatric patients with moderate to severe TBI.
  • To determine the frequency of coagulopathy in this patient group.
  • To investigate the relationship between coagulopathy, trauma severity, and mortality in pediatric TBI.

Main Methods:

  • A cross-sectional study was conducted on 301 pediatric patients (up to 16 years) admitted to the ICU with moderate to severe TBI.
  • Coagulation profiles were analyzed in conjunction with clinical, epidemiological, and CT scan findings.
  • Univariate and multivariate analyses were employed to assess associations between coagulopathy and mortality.

Main Results:

  • Coagulopathy was present in approximately 77% of patients and was directly associated with trauma severity.
  • Factors associated with coagulopathy included TBI severity, brain swelling on CT, and chest/abdominal injuries.
  • Mortality was approximately 35%, with increased risk linked to hyponatremia, hypotension, and acute respiratory distress syndrome.

Conclusions:

  • Coagulopathy is a frequent complication in pediatric patients with moderate to severe TBI.
  • While not directly associated with increased mortality in this study, coagulopathy serves as a significant marker of injury severity.
  • Further research may explore targeted interventions for coagulopathy in pediatric TBI.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...